BART is heading to CPHI Europe 2026, where we will showcase our innovative ingredient solutions and the latest developments within the Liposovit® portfolio. Visit us at stand 7D54 to discover how our liposomal technology can support the development of modern nutraceutical and pharmaceutical formulations.
This year, we will put a particular spotlight on Liposovit®-Creatine and Liposovit®-Glutathione – two solutions that demonstrate how our liposomal platform is expanding beyond vitamins and minerals into a broader range of functional active ingredients.
Liposovit®-Creatine – a new approach to an established active ingredient
Creatine is one of the most recognised and extensively used active ingredients in sports and active nutrition. With Liposovit®-Creatine, BART brings this established ingredient into our liposomal powder platform.
One of the key advantages of Liposovit®-Creatine is its excellent solubility, providing new possibilities for product developers looking beyond conventional creatine formats. Its powdered form also offers flexibility for incorporation into a variety of nutraceutical applications.
The development of Liposovit®-Creatine reflects an important direction for our R&D: applying liposomal technology not only to vitamins and minerals, but also to active ingredients relevant to sports nutrition, active lifestyles and healthy ageing.
Liposovit®-Glutathione – liposomal delivery in a powdered format
Another key highlight at CPHI Europe will be Liposovit®-Glutathione, our liposomal reduced glutathione in powder form.
Glutathione continues to attract interest from the nutraceutical industry, particularly in formulations developed around antioxidant support, healthy ageing and beauty-from-within. At the same time, its characteristics make the choice of delivery system an important consideration when developing new formulations.
Liposovit®-Glutathione combines reduced glutathione with BART’s liposomal technology in a stable powdered format, developed with the formulation and application needs of nutraceutical manufacturers in mind.
Liposomal technology designed for formulation possibilities
At BART, we approach liposomal technology not only from the perspective of the ingredient itself, but also its potential application.
Our Liposovit® ingredients are available in powder form, offering manufacturers flexibility when developing different dosage forms and product concepts. The portfolio includes liposomal vitamins, minerals and an expanding range of other active ingredients.
Supported by our R&D and Application Laboratory Center, we work with customers on solutions ranging from individual Liposovit® ingredients to customised blends and application concepts.
Our continuously expanding portfolio demonstrates the potential of liposomal technology as a versatile delivery platform for the next generation of nutraceutical formulations.
Meet BART at CPHI Europe 2026
CPHI Europe brings together pharmaceutical and nutraceutical professionals from across the global industry, making it an important opportunity to exchange knowledge, discuss formulation challenges and explore new development possibilities.
Visit BART at stand 7D54 to discover Liposovit® Creatine, Liposovit®-Glutathione and our wider portfolio of liposomal ingredients.
Our team will be ready to discuss your formulation needs, application possibilities and opportunities to develop innovative solutions using Liposovit® technology.